741698-83-9

Basic information

• Product Name: 4-bromo-2-isopropylbenzoic acid
• Synonyms: 4-bromo-2-isopropylbenzoic acid
• CAS NO: 741698-83-9
• Molecular Formula: C10H11BrO2
• Molecular Weight: 243.09714
• Mol File: 741698-83-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-bromo-2-isopropylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-isopropylbenzoic acid(741698-83-9)
• EPA Substance Registry System: 4-bromo-2-isopropylbenzoic acid(741698-83-9)

Safety Data

• Hazardous Substances Data: 741698-83-9(Hazardous Substances Data)

Upstream product

• 643094-19-3 methyl 4-bromo-2-isopropylbenzoate 
• 81090-34-8 4-bromo-2-isopropyl-aniline 
• 124-38-9 carbon dioxide 
• 1147014-97-8 4-bromo-1-iodo-2-isopropylbenzene 
• 643-28-7 2-isopropylaniline 
• 68837-59-2 4-bromo-2-methylbenzoic acid 
• 644984-78-1 4-bromo-2-ethylbenzoic acid 
• 74-88-4 methyl iodide 

Relevant articles and documents

CYCLIC AMIDE DERIVATIVE

Provided is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. (In the formula, A is C6-10 arylene, etc.; R1a, R1b and R1c each independently is a hydrogen atom, a halogen atom, a C1-4 alkyl group, a C1-4 alkoxy group, etc.; R2 is an optionally substituted C6-10 aryl group, an optionally substituted 5- to 12-membered monocyclic or polycyclic heteroaryl group, an optionally substituted C7-16 aralkyl group, etc.; m is 0, etc.; n is an integer of 0 to 2.)

1H-PYRROLO[2,3-B]PYRIDINES

Derivatives of pyrrolo[2,3-b]pyridine which are useful as SGK-1 kinase inhibitors are described herein. The invention described herein also describes pharmaceutical compositions containing derivatives of pyrrolo[2,3-b]pyridine and methods of using pyrrolo[2,3-b]pyridine derivatives and pharmaceutical compositions thereof in the treatment of diseases mediated by SGK-1.

AMINO ALCOHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND USE THEREOF

The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R1 and R2 are each hydrogen or lower alkyl; R3 R4, R5 and R6 are each hydrogen, halogen, lower alkyl or lower alkoxy; R7 and R8 are each hydrogen, halogen, lower alkyl, halo-lower alkyl, lower alkoxy, cycloalkyl, aryl, heteroaryl, cyano, a hydroxyl group, lower acyl, carboxy or the like; R9 is -C(O)-R10, -A1-C(O)-R10, -O-A2-C(O)-R10 or a tetrazol-5-yl group, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.